Rituximab-induced hypersensitivity pneumonitis in a kidney transplant patient
Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hypersensitivity pneumonitis associated with a single dose of RTX treatment in a kidney transplanted patient with acute antibody-mediated rejection.
Saved in:
Main Authors: | Silva,Natália, Ribeiro,Catarina Isabel, Almeida,Manuela, Malheiro,Jorge, Pedroso,Sofia, Martins,Maria La Salete, Dias,Leonídio, Henriques,António Castro, Cabrita,António |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Portuguesa de Nefrologia
2020
|
Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692020000300010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ABO-incompatible living donor kidney transplantation in Portugal
by: Ribeiro,Catarina Isabel, et al.
Published: (2020) -
Implications for patients waiting for a kidney transplant of using the calculated panel reactive antibody (cPRA)
by: Magriço,Rita, et al.
Published: (2016) -
Causes hypersensitivity pneumonitis
by: DOE Joint Genome Institute (18794776), et al.
Published: (2009) -
Pancreas-Kidney Transplantation: Analysis of 150 patients from one Centre in Portugal
by: Martins,La Salete, et al.
Published: (2013) -
The first ABO-incompatible kidney transplantation performed in Portugal
by: Barreto,Patricia, et al.
Published: (2015)